Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients
Brachytherapy
.
2013 Sep-Oct;12(5):389-92.
doi: 10.1016/j.brachy.2013.07.004.
Epub 2013 Aug 26.
Authors
Daniel E Spratt
1
,
Michael J Zelefsky
Affiliation
1
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.
PMID:
23988506
DOI:
10.1016/j.brachy.2013.07.004
No abstract available
MeSH terms
Brachytherapy / methods*
Dose-Response Relationship, Radiation
Humans
Male
Prostatic Neoplasms / blood
Prostatic Neoplasms / radiotherapy*
Treatment Outcome